Skip to content
healthcare.dev
Get a free key

Tazorac

NDC 16110-833, tazarotene, gel, from Almirall, LLC.

Product NDC
16110-833
Status
Listed
Labeler
Almirall, LLC
Dosage form
GEL
Route
CUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020600
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16110-833 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE.5 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
16110-833-10161100833101 TUBE in 1 CARTON (16110-833-10) / 100 g in 1 TUBE
16110-833-30161100833301 TUBE in 1 CARTON (16110-833-30) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4e4e4b81-420e-4492-8a74-80b692a80057

Use it

Look up 16110-833 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16110-833 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16110-833. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.